Tisotumab vedotin
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Tisotumab vedotin
Jul 15, 2024, 08:52 |
Blog
Raffaele Colombo: Tisotumab vedotin as 2nd or 3rd line therapy for recurrent cervical cancer
Raffaele Colombo shared a post on X about recent paper by Ignace Vergote et al.…
Jul 11, 2024, 09:55 |
Insight
Piotr Wysocki: Tisotumab vedotin improves outcomes of patients with recurrent cervical cancer
Piotr Wysocki recently posted on LinkedIn: "Vergote I et al. published results of a phase III…
All:
2
Posts:
1 - 100
Amazing Results! President Lynn M. Schuchter on ASCO 2024
OncoDaily Magazine - Inaugural Issue
Penilla Gunther: Reducing Inequities in Cancer Care Demands Collaboration
Best of ASCO Kazakhstan
Oncologist Near Me - Lillian Siu: Curiosity-Driven Cancer Innovator
Facebook
RSS Feed
Twitter
Linkedin
Youtube